NPCE - Rasio utang marang kapitalisasi buku NeuroPace Inc

Logo korporat perusahaan NeuroPace, Inc. (NPCE)

NeuroPace, Inc. (NPCE) develops an advanced neurostimulator that functions as a pacemaker for the brain, treating epilepsy through continuous activity analysis. Profit growth is driven by the expansion of the implant network and service maintenance, which reduces R&D costs. Success is based on physician adoption of the method and insurance reimbursements, with the indicator standing at 5.81. This chart of current share prices confirms these fundamental theses.

NeuroPace, Inc. - Utang-utang marang kapitalisasi buku NPCE (periode 04.07.2022 - 27.10.2026)
Barang unggulan NeuroPace Medical

This indicator assesses the total liabilities-to-equity ratio, determining the company's reliance on external financing and its overall financial stability. The current value of 5.81 within the historical debt-to-capitalization metrics allows investors to evaluate the leverage risk of NeuroPace, Inc. (NPCE) as it scales the RNS system in the neuromodulation market for refractory epilepsy therapy.

Pesaing NeuroPace, Inc.

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Tactile Systems Technology Inc. TCMD|SNWV - Utang marang modal buku|Outset Medical - Utang-utang marang kapitalisasi buku|Electromed (ELMD) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku LNSR|Utang marang nilai buku AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Utang marang nilai buku|Rasio utang marang aset resik BDMD (bairdmed.com)|EDAP TMS - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Utang-utang marang kapitalisasi buku|LUNG - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku telabio.com|CytoSorbents Corporation (CTSO) - Rasio utang marang nilai buku|SRTS: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Zynex Medical|Utang-utang marang kapitalisasi buku ECOR (electroCore, Inc.)|Utang marang nilai buku vicarioussurgical.com (RBOT)|Utang-utang marang kapitalisasi buku IINN (Inspira Technologies)|seastarmedical.com - Utang-utang marang kapitalisasi buku|IRIX - Rasio utang marang kapitalisasi buku|Intelligent Bio Solutions (INBS) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku beyondair.net XAIR|Profusa, Inc (PFSA) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku